Anti-BCMA antibody-drug conjugates and methods of use
US12043670B2 · kind B2 · utility
0Cited by
4References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2021 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Apr 8, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies, antigen-binding fragments, and conjugates (e.g., antibody-drug conjugates (ADCs) such as those comprising a splicing modulator) that bind to BCMA are disclosed. The disclosure further relates to methods and compositions for use in the treatment of cancer by administering a composition provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.